OUR PRODUCTS
A focused portfolio of human donor-derived tissues, animal-derived matrices, bioceramics, and natural polymers engineered to support bone and soft tissue regeneration.
OUR PRODUCTS
A focused portfolio of human donor-derived tissues, animal-derived matrices, bioceramics, and natural polymers engineered to support bone and soft tissue regeneration.
01 / PRODUCT TYPES
Each platform offers a distinct combination of architecture, biological interaction, handling, and remodeling—giving product developers and clinical partners a broader palette for regenerative solutions.
Human donor-derived matrices for bone regeneration.
→ 02
Animal-derived scaffolds for lasting structural support.
→ 03
Synthetic mineral systems for bone growth and integration.
→ 04
Collagen-based matrices for cellular and tissue repair.
→02 / MATERIAL PORTFOLIO
Derived from the dense outer layer of donor bone, these particulates retain their natural mineral content and provide an osteoconductive scaffold for cell attachment, migration, and new bone growth. Their slower remodeling profile can help preserve graft volume during healing.
Human donor-derived boneProduced from the porous inner portion of donor bone, cancellous particulates retain an interconnected architecture that supports cell attachment, blood vessel ingrowth, and new bone formation. They typically remodel faster than dense cortical bone.
Human donor-derived boneCancellous chips preserve natural mineral content and interconnected porosity in a larger format. They can provide greater graft volume and improved space maintenance while supporting biological incorporation and remodeling.
Human donor-derived boneThis blend combines dense cortical and porous cancellous particles. The cortical component supports prolonged space maintenance, while the cancellous component promotes vascularization and biological incorporation.
Human donor-derived bone blendProcessing removes most mineral while preserving the organic bone matrix. In addition to providing an osteoconductive scaffold, properly processed demineralized cortical bone may demonstrate osteoinductive potential.
Demineralized human boneElongated fibers preserve the collagen-rich extracellular matrix and naturally occurring bone-associated proteins. Their interlocking structure can improve cohesion while supporting new bone growth and potential osteoinductive activity.
Demineralized human boneOrganic components are removed while the natural mineral architecture is preserved. The resulting osteoconductive scaffold supports cell attachment, vascular ingrowth, and new bone formation while helping maintain graft volume.
Bovine-derived mineral scaffoldThe membrane surrounding the porcine heart is processed to remove cells and potentially immunogenic components while preserving its extracellular matrix. Its dense architecture can support guided tissue or bone regeneration.
Porcine extracellular matrixTCP resembles the mineral phase of natural bone and provides an osteoconductive surface for bone-forming cells. Its resorption profile can be tailored through crystalline phase, porosity, and particle size.
Synthetic calcium phosphateType I collagen is a primary structural protein in skin, tendon, and bone. Purified porcine collagen provides an extracellular matrix-like scaffold that supports cell attachment, migration, and tissue repair.
Purified porcine collagenEnzymatic removal of terminal telopeptide regions reduces antigenicity while preserving the collagen triple helix. Atelocollagen can be formed into gels, sponges, membranes, plugs, or composite grafts.
Purified bovine atelocollagenWe collaborate with surgeons, distributors, and healthcare partners to bring innovative regenerative solutions to more patients.
JOB INQUIRY
Submit your inquiry to info@sigmagraft.com about a job opportunity or submit your resume.
Elcin Chang is the Executive Vice President of SigmaGraft Biomaterials, where he oversees the research and development of next-generation biomaterials, the manufacture of high-quality medical devices, and the company’s private-label business segment.
Elcin Chang joined SigmaGraft in 2019, initially working in legal and regulatory affairs before becoming involved in nearly every aspect of the business, from research and development to manufacturing. He graduated from the University of San Diego with a degree in political science and joined the U.S. Army Reserve after college. He later earned both a law degree and an M.B.A. from the University of Maryland.
Outside of work, Elcin enjoys traveling and playing sports. He is deeply committed to his work, family, church, and community.